News Posted on February 4, 2026 Preclinical stem cell biotech PrimeGen takes SPAC route to Nasdaq – Fierce Biotech Preclinical stem cell biotech PrimeGen takes SPAC route to Nasdaq Fierce Biotech Source: Preclinical stem cell biotech PrimeGen takes SPAC route to Nasdaq – Fierce Biotech By sf-admin